233 related articles for article (PubMed ID: 20830288)
1. Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity.
Ruhaak LR; Uh HW; Beekman M; Koeleman CA; Hokke CH; Westendorp RG; Wuhrer M; Houwing-Duistermaat JJ; Slagboom PE; Deelder AM
PLoS One; 2010 Sep; 5(9):e12566. PubMed ID: 20830288
[TBL] [Abstract][Full Text] [Related]
2. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.
Baković MP; Selman MH; Hoffmann M; Rudan I; Campbell H; Deelder AM; Lauc G; Wuhrer M
J Proteome Res; 2013 Feb; 12(2):821-31. PubMed ID: 23298168
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
Kodar K; Stadlmann J; Klaamas K; Sergeyev B; Kurtenkov O
Glycoconj J; 2012 Jan; 29(1):57-66. PubMed ID: 22179780
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
[TBL] [Abstract][Full Text] [Related]
5. IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age.
Twisselmann N; Bartsch YC; Pagel J; Wieg C; Hartz A; Ehlers M; Härtel C
Front Immunol; 2018; 9():3166. PubMed ID: 30713537
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Wuhrer M; Selman MH; McDonnell LA; Kümpfel T; Derfuss T; Khademi M; Olsson T; Hohlfeld R; Meinl E; Krumbholz M
J Neuroinflammation; 2015 Dec; 12():235. PubMed ID: 26683050
[TBL] [Abstract][Full Text] [Related]
7. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
[TBL] [Abstract][Full Text] [Related]
8. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
9. High-throughput rat immunoglobulin G N-glycosylation profiling revealed subclass-specific changes associated with chronic stress.
Habazin S; Mlinarević D; Balog M; Bardak A; Gaspar R; Szűcs KF; Vari SG; Vučković F; Lauc G; Novokmet M; Heffer M
J Proteomics; 2021 Aug; 245():104293. PubMed ID: 34118474
[TBL] [Abstract][Full Text] [Related]
10. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.
Zou G; Ochiai H; Huang W; Yang Q; Li C; Wang LX
J Am Chem Soc; 2011 Nov; 133(46):18975-91. PubMed ID: 22004528
[TBL] [Abstract][Full Text] [Related]
12. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
13. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.
de Haan N; Reiding KR; Driessen G; van der Burg M; Wuhrer M
J Proteome Res; 2016 Jun; 15(6):1853-61. PubMed ID: 27161864
[TBL] [Abstract][Full Text] [Related]
14. Regulation of antibody effector functions through IgG Fc N-glycosylation.
Quast I; Peschke B; Lünemann JD
Cell Mol Life Sci; 2017 Mar; 74(5):837-847. PubMed ID: 27639381
[TBL] [Abstract][Full Text] [Related]
15. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J; Zheng YZ; James DC
Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
[TBL] [Abstract][Full Text] [Related]
16. The
de Haan N; Reiding KR; Krištić J; Hipgrave Ederveen AL; Lauc G; Wuhrer M
Front Immunol; 2017; 8():608. PubMed ID: 28620376
[No Abstract] [Full Text] [Related]
17. Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases.
Zhang D; Chen B; Wang Y; Xia P; He C; Liu Y; Zhang R; Zhang M; Li Z
Sci Rep; 2016 May; 6():25957. PubMed ID: 27173519
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Association Study on Immunoglobulin G Glycosylation Patterns.
Wahl A; van den Akker E; Klaric L; Štambuk J; Benedetti E; Plomp R; Razdorov G; Trbojević-Akmačić I; Deelen J; van Heemst D; Slagboom PE; Vučković F; Grallert H; Krumsiek J; Strauch K; Peters A; Meitinger T; Hayward C; Wuhrer M; Beekman M; Lauc G; Gieger C
Front Immunol; 2018; 9():277. PubMed ID: 29535710
[TBL] [Abstract][Full Text] [Related]
19. Mouse milk immunoglobulin G Fc-linked N-glycosylation nano-LC-MS analysis in a model of vancomycin exposure during pregnancy.
Alhasan MM; Habazin S; Kahhaleh FG; Lauc G; Conrad ML; Novokmet M
Anal Bioanal Chem; 2023 May; 415(12):2239-2247. PubMed ID: 36914840
[TBL] [Abstract][Full Text] [Related]
20. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
Front Immunol; 2020; 11():2049. PubMed ID: 32973813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
